Navigation Links
CryoCath Announces Fiscal 2008 Second Quarter Results
Date:5/12/2008

loss on foreign

exchange embedded

derivatives (18,464) 43,679 (41,175) (14,022)

Unrealized foreign

exchange loss

(gain) (564,930) 58,092 (611,427) 58,092

Accretion in balance

of sale receivable (56,403) - (112,025) -

-------------------------------------------------------------------------

(5,403,590) (3,616,482) (10,339,599) (5,252,592)

Net change in

non-cash working

capital balances

relating to

operations 1,144,263 (1,774,460) (2,662,821) (3,000,842)

Decrease in net

investments

in leases - - - 5,967

(Decrease) increase

in deferred revenue 68,233 29,041 30,335 178,309

-------------------------------------------------------------------------

Cash flows related

to operating

activities (4,191,094) (5,361,901) (12,972,085) (8,069,158)

-------------------------------------------------------------------------

INVESTING ACTIVITIES

Proceeds from

maturities of

short-term

investments 7,929,494 1,992,697 12,892,248 5,616,907

Decrease (increase)

in cash subject

to restrictions (840,625) 109,375 (687,500) (1,531,250)

Acquisition of

intellectual

property (86,743) (112,800) (155,949) (223,192)

Acquisition of

property, plant,

and equipment (74,755) (292,459) (125,752) (573,956)

Placement of

consoles at

customers'

premises (359,885) (499,429) (740,554) (926,008)

-------------------------------------------------------------------------

------------------------------------------------
'/>"/>

SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. CryoCath to Hold Second Quarter 2008 Conference Call and Webcast
2. CryoCath Reports Data Presented at the 74th Annual Meeting of the German Cardiac Society
3. CryoCath Introduces Arctic Front in Australia
4. CryoCath Appoints New Chief Financial Officer
5. CryoCath Technologies notice of annual meeting
6. CryoCath Announces Fiscal 2008 First Quarter Results
7. CryoCath Provides Update on Patent Infringement Lawsuit
8. CryoCath to Hold First Quarter 2008 Conference Call and Webcast
9. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
10. CryoCath announces 2007 fourth quarter and fiscal year end financial results
11. CryoCath to present at Piper Jaffray and BMO Healthcare conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...partment of Defense and Federal Agencies in, the ...olden Phoenix is a, four-day, multi-agency colla...l, state and local agencies with large and complex...ding a vital, ad-hoc, secure mobile communicatio...ise., NORFOLK, Va., July 25 /PRNewswire/ -- Datal...
(Date:7/25/2008).../ -- The Elekta Family of Companies will,showcase ... the 2008,American Association of Physicists in Me...e joint forces of Elekta, IMPAC and CMS are delive...elivery solutions that,streamline the treatment pr...as well as enhance clinician efficiency., "Our re...
(Date:7/25/2008)...ogram delivers immediate cost savings for http://...ss to language interpreters] to firms switching l...s. , Washington, D.C. (V...e-inc.com/index.html [(Language Learning Enterpri... translation, and language instruction services to...
(Date:7/25/2008)...us-based law firm represents Pickerington man who ...olumbus-area Kroger store , ...http://www.donaheyohioinjurylawyers.com [The Dona...law firms in central Ohio, has filed a product lia...08CV9804) against The Kroger Co., in connection wi...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2
... between Hewlett Packard and the government in Nor...r prescriptions towards the implementation// of an...lth Social Services and Public Safety has announce...ern Ireland will be equipped with an electronic sy...
...ll have a new medical college from the next academ...ednesday that the proposed medical college will be...n addition to the new campus of the Rajiv Gandhi U... said, "The revenue department will identify alter...
...has revealed that those who drink coffee very rare...heavy drinkers.// According to a study in the Sep...ple could get a heart attack within one hour of ha...k of almost 60% amongst moderate coffee drinkers, ...
..."Pascal" Norris, who died in July, is thought to b...an two decades in Scotland. NHS Borders revealed t...ied on 8 July in Edinburgh Royal Infirmary and lat...died of anthrax. Health Protection Scotland said ...
Other Medicine News:
(Date:7/23/2008)... Protein Therapeutics that Modulate Alte...Mass., July 23 /- Taligen Therapeutic...e growth plan with the,appointment of Abbie Celnik...blishment of its headquarters in Cambridge, Mass. ...ounder of the company who remains president., Und...
(Date:7/22/2008)...ent Initiative bring MJFF,s,current active industr...2009, NEW YORK, July 22 /PRNewswire-USNewswire/ -...sformative treatments and a cure for Parkinson,s,d...n,s Research has awarded,$2.7 million in total fun...re granted under MJFF,s Therapeutics Development I...
(Date:7/22/2008)...a(R) Resulted in Significant, Reductions in A1C in...ithm Used, BRIDG... the "Adjust to,Target in Type 2 Diabetes: Compari... for Adjustment of Mealtime Insulin Glulisine" stu...ation,s (ADA) medical journal,Diabetes Care. This...
(Date:7/22/2008)...ersity Medical Center Based on Rosetta G...st Differentiates Squamous From Non-Squamous Non-S...us-Cell Carcinoma of the Lung With Sensitiv...is is the First CLIA Approved Test Which Leverages... Accurate Diagnosis of Lung Cancer, REHOVOT, Isra...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Hip replacement improves function saves money at any age 21969 1Hip replacement improves function saves money at any age 21969 2LIAI researchers discover new cellular mechanism that will significantly advance vaccine development 3650 1LIAI researchers discover new cellular mechanism that will significantly advance vaccine development 3650 2Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone 21964 1Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone 21964 2Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi Year Contract for Diagnostic Services 21961 1Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi Year Contract for Diagnostic Services 21961 2
... patients taking,once-daily Lialda remained relaps...May 22, 2007 /PRNewswire-FirstCall/ -- A,long-term... (303),presented at the British Society of Gastroe...rch 2007 showed Shire plc,s,Lialda(mesalamine) is ...day, secondary endpoints of study 303 were present...
... Doses, According to,New Data Presented at Digesti...wswire/ -- UCB announced today that,new data prese...ated long-term response and remission in Crohn,s d...pegol), the only Fc-free,PEGylated, Fab, fragment ... long-term open label,continuation of the Phase II...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8UCB Presents Long-Term CImzia Data in Crohn's Disease 2UCB Presents Long-Term CImzia Data in Crohn's Disease 3UCB Presents Long-Term CImzia Data in Crohn's Disease 4UCB Presents Long-Term CImzia Data in Crohn's Disease 5
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: